Rising Incidence Of Chronic Diseases Boosts Growth In The Peptide Synthesis Market: Strategic Insights Driving Peptide Synthesis Market Momentum in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Peptide Synthesis Market Size By 2025?
The market encompassing peptide synthesis has experienced robust expansion recently, projecting an increase from its 2024 valuation of $5.69 billion to $6.18 billion in 2025, reflecting an 8.6% compound annual growth rate throughout this span; this upward trajectory during the past period is largely attributable to escalating requirements for peptide-derived vaccines, advancements within biotechnology and biopharmaceutical sectors, a sustained need for exceptionally pure peptides, alongside the impact of regulatory clearances and established standards.

How Big Is the Peptide Synthesis Market Size Expected to Grow by 2029?
The peptide synthesis market size is projected to experience significant growth over the next few years. It is expected to $8.92 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The anticipated growth during the forecast period can be attributed to the rapid expansion of therapeutic peptides, increasing demand for customized peptides, growing importance in drug discovery and development, and rising focus on peptide libraries for screening applications. Key trends in the forecast period include the development of peptide mimetics, use of novel amino acid derivatives, advancements in peptide cyclization methods, innovations in solid-phase peptide synthesis (SPPS), and the incorporation of click chemistry techniques.

View the full report here:
https://www.thebusinessresearchcompany.com/report/peptide-synthesis-global-market-report

Which Key Market Drivers Powering Peptide Synthesis Market Expansion and Growth?
The increasing prevalence of long-duration, non-communicable ailments, characterized as chronic diseases, is projected to fuel the expansion of the market for peptide synthesis. Since certain peptides possess anti-inflammatory and antioxidant properties, their application in managing chronic illnesses, such as cardiovascular conditions, is significant, potentially assisting in prevention. Peptides offer fresh avenues for both therapeutic intervention and disease management by focusing on specific cellular mechanisms and signaling cascades that underpin the root causes of these protracted health issues. Reflecting this trend, data from the Australian Institute of Health and Welfare indicated that in 2022, the age-adjusted mortality rate linked to chronic conditions in Australia stood at 490 deaths per 100,000 people, marking an increase from the 459 per 100,000 recorded the previous year, thereby underscoring how the rising burden of chronic conditions is propelling the peptide synthesis sector forward.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13295&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Peptide Synthesis Market?
Leading entities within the peptide synthesis sector are concentrating their efforts on launching superior peptide synthesizers, exemplified by the PurePep Sonata+, as a means to establish a stronger position among competitors. The PurePep Sonata+ stands out as a sophisticated peptide synthesizer, providing enhancements in operational speed, precision, and overall efficacy when contrasted with older models. Specifically, in March of 2022, Gyros Protein Technologies, a firm headquartered in the United States specializing in peptide synthesis and bioanalytical technology provisions, unveiled this PurePep Sonata+ peptide synthesizer. This new apparatus builds upon the functionality of the Sonata XT by integrating technology that allows for flow monitoring in real time; this novel method facilitates the constant oversight of fluid movement inside the apparatus, thereby offering a technique that does not interfere with the process itself, guaranteeing faithful and exact transfer of liquids across various thickness levels.

What Are the Emerging Segments in the Peptide Synthesis Market?
The peptide synthesismarket covered in this report is segmented -

1) By Product And Service: Reagents; Equipment; Services
2) By Technology: Solid-Phase Peptide Synthesis; Solution-Phase Peptide Synthesis; Hybrid And Recombinant Technology
3) By End User: Pharmaceutical And Biotechnology companies; Contract Manufacturing And Development Organizations (CDMOs) And Contract Research Organizations (CROs); Academic And Research Institutes

Subsegments:
1) By Reagents: Amino Acids; Coupling Reagents; Protecting Groups; Cleavage Reagents
2) By Equipment: Peptide Synthesizers; Chromatography Systems; Mass Spectrometers; Other Analytical Instruments
3) By Services: Custom Peptide Synthesis; Peptide Characterization And Analysis; Peptide Modification Services; Consulting And Support Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13295&type=smp

Who Are the Global Leaders in the Peptide Synthesis Market?
Major companies operating in the peptide synthesis market report are Thermo Fisher Scientific, Novo Nordisk A/S, Merck KGaA, Lonza Group, Kaneka Corporation, Uno Minda, Guizhou Xinbang Pharmaceutical Co. Ltd., Hybio Pharmaceutical Co. Ltd., GenScript Biotech, Bachem Holding AG, Syngene International, PolyPeptide Group AG, Mesa Labs Inc., CPC Scientific Inc., New England Peptide Inc., Biotage, ScinoPharm Taiwan Ltd., MP Biomedicals, USV Private Limited, CEM Corporation, Enamine Ltd., Creative Diagnostics, AnaSpec Inc., CSBio Company Inc., Alfa Chemistry, Advanced ChemTech, Gyros Protein Technologies AB, AAPPTec LLC, Biosynth International Inc., ProteoGenix

Which are the Top Profitable Regional Markets for the Peptide Synthesis Industry?
North America was the largest region in the peptide synthesis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13295

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.